AMERISEPlastic Products - Industrial
Amerise Biosciences Ltd — Cash Flow Statement
₹0.59
-4.62%
Amerise Biosciences Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 3.07 Cr | -0.17 Cr | -0.13 Cr | 0.06 Cr | — |
| End Cash Position | 0.02 Cr | 0.02 Cr | 0.01 Cr | 0.01 Cr | — |
| Beginning Cash Position | 0.02 Cr | 0.01 Cr | 0.01 Cr | 0.02 Cr | — |
| Changes In Cash | 11000.00 | 75000.00 | 7000.00 | -64000.00 | — |
| Financing Cash Flow | 0.00 | -0.09 Cr | 73000.00 | 0.08 Cr | — |
| Interest Paid Cff | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 0.00 | -0.09 Cr | 73000.00 | 0.08 Cr | — |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 73000.00 | 0.08 Cr | — |
| Net Long Term Debt Issuance | 0.00 | -0.09 Cr | 0.00 | 0.00 | — |
| Investing Cash Flow | -3.07 Cr | 0.27 Cr | 0.13 Cr | -0.15 Cr | — |
| Net Investment Purchase And Sale | -0.12 Cr | 2.30 Cr | 0.13 Cr | -1.65 Cr | — |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | 3.07 Cr | -0.17 Cr | -0.13 Cr | 0.06 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | 3.06 Cr | -0.02 Cr | -0.01 Cr | -0.49 Cr | — |
| Change In Other Current Liabilities | 3.07 Cr | -0.02 Cr | 0.04 Cr | -0.06 Cr | — |
| Change In Other Current Assets | -29000.00 | -18000.00 | 0.00 | 0.00 | — |
| Change In Inventory | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Receivables | 0.00 | 0.00 | 6.22 Cr | -6.22 Cr | — |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 76000.00 | -0.15 Cr | -0.12 Cr | 0.55 Cr | — |
| Interest Received Cfi | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | -1000.00 | 1000.00 | — |
| Change In Payable | — | — | -6.27 Cr | 5.79 Cr | — |
| Purchase Of Investment | — | — | — | -1.65 Cr | — |
| Net Business Purchase And Sale | — | — | — | -1.65 Cr | 2.33 Cr |
| Sale Of Investment | — | — | — | — | 2.33 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Amerise Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.